Clinical trial
Orlistat for the Treatment of Type I Hyperlipoproteinemia
NCT02767531 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Orlistat for the Treatment of Type I Hyperlipoproteinemia
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- December 31, 2022
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.